. @AmericanCancer estimates 8% of cancer patients participate in a clinical trial. At @ACSCAN forum today solving barriers to clinical trials. @UFHealthCancer
Registration now open for #NatlCancerForum wksp on the clinical application of computational methods in precision oncology October 29 & 30 in DC: https://t.co/lIxGZA65Qk
Thanks to Leukemia Dream Team of coauthors. Disparities in wealth, insurance access, and genetic testing (not age nor fitness) link to who gets life-saving treatment for AML. Health policy fixes needed. @LLSusa@AmericanCancer#ASCO18#ASCO2018 https://t.co/TRRddruXfA
Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry - @chris_cogle et al. #ASCO18 Poster 97, abstract 7037 - Monday June 4, 8:00 AM to 11:30 AM https://t.co/lauh6WwCSN #AMLsm#leusm
@ramzi_salloum@DrMarkham Can’t beat a medical economist’s pen+highlighter combo. That’s some A level fun for kids and grown-ups. Good seeing you too, @ramzi_salloum.
Today, it was my honor and privilege to show @ChilesElem kindergarteners the science and art of being a doctor. Great listeners who used their ears, eyes and hearts. Special thanks to @UFHealthCancer for the squishy alligators for Med School Class of 2041.
Proud of Dr. Leylah Drusbosky for 2 presentations at #AACR18 on using genomics and computational biology to bring much needed precision in caring for cancer patients. @UFHealthCancer@DemandCures
Congratulations to Chris Cogle and Vindhya Vijay and their oral presentation at AACR on delineating a new target in acute myeloid leukemia and a potential therapeutic approach